Smart vest for heart patients: could it cut hospital readmissions?
NCT ID NCT07622472
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a wearable device that tracks heart rate, breathing, activity, and fluid buildup in people recently hospitalized for heart failure. 800 participants will either get standard care or standard care plus the device for 90 days. The goal is to see if early alerts from the device help doctors prevent serious events like death or rehospitalization.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Wearable monitoring device (Heart Failure Management System)
What this could lead to
If successful, this device could help doctors detect worsening heart failure early and reduce hospital visits and deaths.
What could go wrong
The trial hasn't started yet, and it's unclear if the device will meaningfully improve outcomes over standard care. Device data may lead to false alarms or missed warnings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Nancy
Nancy, Grand Est, 54000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario 12 de Octubre
Madrid, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Justus-Liebig University Giessen
Giessen, 35390, Germany
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
PIM MSWiA Hospital
Warsaw, Poland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Policlinico Casilino
Roma, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Southampton University Hospital NHS Foundation Trust
Southampton, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UMC Utrecht
Utrecht, Netherlands
-
University Zurich
Zurich, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Uppsala University Hospital
Uppsala, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••